BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 6653924)

  • 1. Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension.
    Pastrovic F; Novak R; Grgurevic I; Hrkac S; Salai G; Zarak M; Grgurevic L
    PLoS One; 2024; 19(4):e0301416. PubMed ID: 38603681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin and the critically ill patient: current status.
    Saba TM; Kiener JL; Holman JM
    Intensive Care Med; 1986; 12(5):350-8. PubMed ID: 3534039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal fibronectin levels after surgical treatment of portal hypertension in liver cirrhosis.
    De Angelis V; Zambon M; Toffolo L; Voltan GP; Orazi BM; Santarossa L; Donada C; Zuin R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):89-93. PubMed ID: 1695189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin decrease in liver cirrhosis is related to spleen size.
    de Angelis V; Zambon M; Toffolo L; Donada C; Molaro GL; Zuin R
    Klin Wochenschr; 1988 Jun; 66(12):524-6. PubMed ID: 3419082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Porto-systemic shunts in children: Schneider Children's Medical Center experience].
    Mor E; Bar-Nathan N; Shapira R; Katchko M; Dinari G
    Harefuah; 2002 Nov; 141(11):953-6, 1011. PubMed ID: 12476627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin as a prognostic indicator in portal hypertension.
    McKee RF; Maharaj DP; Garden OJ; Carter DC
    HPB Surg; 1992 Jun; 5(4):229-34. PubMed ID: 1390363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension.
    Hosokawa I; Adam R; Allard MA; Pittau G; Vibert E; Cherqui D; Sa Cunha A; Bismuth H; Miyazaki M; Castaing D
    Br J Surg; 2017 Mar; 104(4):443-451. PubMed ID: 28079252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low fibronectin in portal hypertension.
    Foster PN; Bowen M; Howdle PD; Losowsky MS
    Digestion; 1983; 28(2):122-4. PubMed ID: 6653924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of portal hypertension in patients with liver cirrhosis].
    D'Albuquerque LA; de Oliveira e Silva A; Pinto JĂșnior PE; de Miranda MP; Genzini T; Gama-Rodrigues JJ
    Arq Gastroenterol; 1988; 25(4):218-23. PubMed ID: 3077244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of portal hypertension in children.
    de Ville de Goyet J; D'Ambrosio G; Grimaldi C
    Semin Pediatr Surg; 2012 Aug; 21(3):219-32. PubMed ID: 22800975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correction of secondary hypersplenism in the surgical treatment of portal hypertension].
    Kalita NIa; Bulanov KI; Kotenko OG
    Vestn Khir Im I I Grek; 1991 Mar; 146(3):137-40. PubMed ID: 1654623
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.